Bristol-Myers Squibb enters clinical collaboration agreement with Tibotec Pharmaceuticals
2 December 2011 | By Bristol-Myers Squibb Company
Phase II combination study in patients chronically infected with Hepatitis C...
List view / Grid view
2 December 2011 | By Bristol-Myers Squibb Company
Phase II combination study in patients chronically infected with Hepatitis C...
15 November 2011 | By Gilead Sciences
Gilead Sciences, Inc. has entered into a license agreement with Tibotec Pharmaceuticals...
21 October 2011 | By Janssen Pharmaceuticals Inc.
New HIV data to be presented at EACS 2011...
28 June 2011 | By Gilead Sciences, Inc.
Development and commercialization of a new fixed-dose antiretroviral combination product...